Brief: Alpine Immune Sciences Q1 EPS USD -0.28 Vs. IBES Estimate USD -0.41
09/05/2024 21:00
May 09 (Reuters) - Alpine Immune Sciences Q1 collaboration revenue USD 7.032 million. * Q1 income from operations USD -22.696 million vs. IBES estimate USD -25 million * Q1 net income USD -17.918 million vs. IBES estimate USD -23.9 million * Q1 operating expenses USD 29.728 million
Recent news on Alpine Immune Sciences
See all newsAlpine Immune Sciences Inc reports results for the quarter ended in January - Earnings Summary
Brief: Alpine Immune Sciences Q1 EPS USD -0.28 Vs. IBES Estimate USD -0.41
Moves: Lazard hires veteran healthcare dealmaker Colocci as vice chairman
U.S. RESEARCH ROUNDUP-Cheesecake Factory, Netflix, Texas Roadhouse
US STOCKS-S&P 500, Nasdaq end sharply higher on soft inflation data, eyes on earnings